New York - Pfizer faces a shareholder lawsuit over its takeover of multi-billion dollar rival Wyeth, with the smaller firm's stockholders alleging the deal undervalues the company, Bloomberg financial news reported Friday.
The world's largest pharmaceuticals maker Pfizer Inc announced Monday that it would purchase Wyeth in a deal worth 68 billion dollars.
The suit filed by Wyeth shareholders in a Newark, New Jersey court on Tuesday alleges the firm's directors breached their duty by not getting a better price.